Media Releases

2021

16/12/2021

Proteomics wins biotech testing contract – The West Australian

16/12/2021

Proteomics secures major pharmacokinetic testing contract

14/12/2021

Proteomics International Laboratories (ASX:PIQ) receives $1.2 million R&D incentive – The Market Herald

24/11/2021

FDA advises regulatory pathway for PromarkerD in US

23/11/2021

Proteomics enters lucrative UK market for kidney test – The West Australian

23/11/2021

PromarkerD distribution network expands to Britain – Yahoo! Finance

23/11/2021

PromarkerD distribution network expands to Britain

16/11/2021

New Directors appointed to Company Board

05/11/2021

PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline – Market Watch

05/11/2021

PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline

03/11/2021

Proteomics (ASX:PIQ) awarded $100,000 project grant – The Market Herald

03/11/2021

Proteomics International awarded $100,000 manufacturing funding

18/10/2021

Clinical study boosts Proteomics kidney test – The West Australian

12/08/2021

Proteomics International Laboratories (ASX:PIQ) contracts Biotem to manufacture test kits – The Market Herald

12/08/2021

Blood test or crystal ball? Looking into the future of our health – The Sentiment

1
…
8
9
10
11
12
13
14
…
27